The contraceptives market in Italy has consistently experienced a decline in value over the past decade. From 2013 to 2023, the market size decreased significantly, with value figures falling from $487.53 million in 2013 to $242.67 million in 2023. This trend demonstrates declining consumer demand for hormonal and spermicide-based contraceptives, influenced by varying factors such as changing preferences, advancements in alternative contraceptive methods, and potential shifts in societal attitudes and medical advice.
Examining the year-on-year variations, the market saw a mixed trend with occasional short-term increases. Specifically, in 2021 and 2022, the market experienced substantial year-on-year declines of -16.26% and -8.18% respectively, followed by another -8.82% decline in 2023. Additionally, the Compound Annual Growth Rate (CAGR) for the five years preceding 2023 was consistently negative at -9.17%, indicating a steady annual decrease in market size during this period.
As we look toward future trends, it is essential to watch for changes in consumer behavior toward contraceptive methods, adoption of newer technologies, and regulatory impacts that may further affect market dynamics. Monitoring the influence of public health initiatives and education on contraceptive options will also be crucial in understanding potential shifts in market demand.
How does Italy rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
